Healthcare -
Biotechnology - NASDAQ - US
$ 4.525
-6.7 %
$ 252 M
Market Cap
-2.45
P/E
FHTX - LONG-TERM DEBT
Long-term Debt FHTX - Foghorn Therapeutics Inc.
36.6 M
LAST VALUE
-15.62%
2 YEAR CAGR
39.06%
5 YEAR CAGR
0.00%
10 YEAR CAGR